Novostia

medical devices

About

Novostia is a Swiss medical device company founded in 2017, located in Epalinges near Lausanne. The company specializes in developing an innovative artificial heart valve, particularly aimed at young patients, including children. Novostia operates within the Biopôle life sciences community, fostering collaboration with leading research and innovation groups. The flagship product, the Triflo valve, is designed to improve the quality of life for patients suffering from aortic and mitral valve diseases. It features lifelong durability, low thrombogenicity to minimize blood clot risks, and a low acoustic signature for quiet operation. The valve has shown promising results in laboratory and animal studies and is preparing for first-in-human clinical trials. Novostia's primary customers include healthcare providers such as hospitals and specialized cardiac centers, as well as patients needing heart valve replacements. The company aims to enhance patient outcomes and reduce healthcare costs by offering a valve that does not require lifelong anticoagulation therapy.

Technologies

Outlook Microsoft Office 365 Mobile Friendly Google Tag Manager Google Maps Google Maps (Non Paid Users) Google Font API Apache

Keywords

heart valves & medical devices medical equipment manufacturing congenital heart defect medical device innovation public health impact valve design regulatory affairs surgical procedures regenerative medicine medical research low acoustic signature healthcare equipment & supplies implantable devices anticoagulant-free valve heart valve replacement cardiovascular device patient safety biomechanics fluid mechanics material science congenital valve repair eu horizon funding patient-specific sizes clinical trials tavr alternative native-like hemodynamics minimally invasive surgery pediatric valve replacement biocompatible polymer bioprosthetic durability

Location

4 Route de la Corniche, Epalinges, Vaud, Switzerland, 1066

Related Companies

Companies in the same industry